These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

589 related items for PubMed ID: 20819196

  • 1. Multicentric evaluation of model for end-stage liver disease-based allocation and survival after liver transplantation in Germany--limitations of the 'sickest first'-concept.
    Weismüller TJ, Fikatas P, Schmidt J, Barreiros AP, Otto G, Beckebaum S, Paul A, Scherer MN, Schmidt HH, Schlitt HJ, Neuhaus P, Klempnauer J, Pratschke J, Manns MP, Strassburg CP.
    Transpl Int; 2011 Jan; 24(1):91-9. PubMed ID: 20819196
    [Abstract] [Full Text] [Related]

  • 2. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.
    Yi NJ, Suh KS, Lee HW, Shin WY, Kim J, Kim W, Kim YJ, Yoon JH, Lee HS, Lee KU.
    Liver Transpl; 2009 May; 15(5):496-503. PubMed ID: 19399732
    [Abstract] [Full Text] [Related]

  • 3. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
    Hayashi PH, Forman L, Steinberg T, Bak T, Wachs M, Kugelmas M, Everson GT, Kam I, Trotter JF.
    Liver Transpl; 2003 Jul; 9(7):737-40. PubMed ID: 12827562
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Model for end-stage liver disease score versus simplified acute physiology score criteria in acute renal failure after liver transplantation.
    Umbro I, Tinti F, Mordenti M, Rossi M, Ianni S, Pugliese F, Ruberto F, Ginanni Corradini S, Nofroni I, Poli L, Berloco PB, Mitterhofer AP.
    Transplant Proc; 2011 May; 43(4):1139-41. PubMed ID: 21620072
    [Abstract] [Full Text] [Related]

  • 10. The model for end-stage liver disease allocation system for liver transplantation saves lives, but increases morbidity and cost: a prospective outcome analysis.
    Dutkowski P, Oberkofler CE, Béchir M, Müllhaupt B, Geier A, Raptis DA, Clavien PA.
    Liver Transpl; 2011 Jun; 17(6):674-84. PubMed ID: 21618688
    [Abstract] [Full Text] [Related]

  • 11. Prediction of survival after liver retransplantation for late graft failure based on preoperative prognostic scores.
    Yao FY, Saab S, Bass NM, Hirose R, Ly D, Terrault N, Lazar AA, Bacchetti P, Ascher NL, Roberts JP.
    Hepatology; 2004 Jan; 39(1):230-8. PubMed ID: 14752842
    [Abstract] [Full Text] [Related]

  • 12. The introduction of MELD-based organ allocation impacts 3-month survival after liver transplantation by influencing pretransplant patient characteristics.
    Weismüller TJ, Negm A, Becker T, Barg-Hock H, Klempnauer J, Manns MP, Strassburg CP.
    Transpl Int; 2009 Oct; 22(10):970-8. PubMed ID: 19619170
    [Abstract] [Full Text] [Related]

  • 13. Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list.
    Ferraz-Neto BH, Hidalgo R, Thomé T, Melo VA, Lobue A, Zurstrassen MP, Moraes JM, Meira-Filho SP, Rezende MB, Fonseca LE, Pandullo FL, Soeiro FS, Afonso RC.
    Transplant Proc; 2007 Oct; 39(8):2511-3. PubMed ID: 17954160
    [Abstract] [Full Text] [Related]

  • 14. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J, Rimola A, Laguno M, de Lazzari E, Rascón J, Agüero F, Blanco JL, Moitinho E, Moreno A, Miró JM, ESLD-HIV Working Group Investigators.
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [Abstract] [Full Text] [Related]

  • 15. The MELD score in patients awaiting liver transplant: strengths and weaknesses.
    Bernardi M, Gitto S, Biselli M.
    J Hepatol; 2011 Jun; 54(6):1297-306. PubMed ID: 21145851
    [Abstract] [Full Text] [Related]

  • 16. True impact of the indication of cirrhosis and the MELD on the results of liver transplantation.
    Santoyo J, Suarez MA, Fernandez-Aguilar JL, Perez Daga JA, Sanchez-Perez B, Ramirez C, Aranda JM, Rodríguez-Canete A, Gonzalez-Sanchez A.
    Transplant Proc; 2006 Oct; 38(8):2462-4. PubMed ID: 17097967
    [Abstract] [Full Text] [Related]

  • 17. Model for End-Stage Liver Disease (MELD) score system to evaluate patients with viral hepatitis on the waiting list: better than the Child-Turcotte-Pugh (CTP) system?
    Cuomo O, Perrella A, Arenga G.
    Transplant Proc; 2008 Oct; 40(6):1906-9. PubMed ID: 18675085
    [Abstract] [Full Text] [Related]

  • 18. Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival.
    Ioannou GN, Perkins JD, Carithers RL.
    Gastroenterology; 2008 May; 134(5):1342-51. PubMed ID: 18471511
    [Abstract] [Full Text] [Related]

  • 19. Living donor liver transplantation in adults in the MELD era in Germany--a multi-center retrospective analysis.
    Settmacher U, Götz M, Rahmel A, Bärthel E, Schlitt H, Puhl G, Broering D, Lehner F, Fischer L, Paul A, Schmidt J, Nadalin S, Obed A, Heise M.
    Transpl Int; 2011 Sep; 24(9):904-11. PubMed ID: 21668530
    [Abstract] [Full Text] [Related]

  • 20. Hepatocellular carcinoma in children and effect of living-donor liver transplantation on outcome.
    Arikan C, Kilic M, Nart D, Ozgenc F, Ozkan T, Tokat Y, Yagci RV, Aydogdu S.
    Pediatr Transplant; 2006 Feb; 10(1):42-7. PubMed ID: 16499586
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.